Synthesis of new pyridothienopyrimidinone derivatives as Pim-1 inhibitors

被引:18
|
作者
Naguib, Bassem H. [1 ,2 ]
El-Nassan, Hala B. [2 ]
Abdelghany, Tamer M. [3 ]
机构
[1] British Univ Egypt, Pharmaceut Chem Dept, Fac Pharm, Cairo, Egypt
[2] Cairo Univ, Pharmaceut Organ Chem Dept, Fac Pharm, Cairo, Egypt
[3] Al Azhar Univ, Dept Pharmacol & Toxicol, Fac Pharm, Cairo, Egypt
关键词
Pyridothienopyrimidine; pyrido[3'2':4,5] thieno[ 3,2-d]pyrimidin-4(3H)-one; cytotoxic activity; pim-1; inhibitors; KINASE INHIBITORS; SERINE/THREONINE KINASES; MULTIPLE-MYELOMA; CANCER-THERAPY; BINDING MODE; CELL-GROWTH; LEUKEMIA; POTENT; DISCOVERY; SURVIVAL;
D O I
10.1080/14756366.2016.1261130
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Four series of pyridothienopyrimidin-4-one derivatives were designed and prepared to improve the pim-1 inhibitory activity of the previously reported thieno[2,3-b] pyridines. Significant improvement in the pim-1 inhibition and cytotoxic activity was achieved using structure rigidification strategy via ring closure. Six compounds (6c, 7a, 7c, 7d, 8b and 9) showed highly potent pim-1 inhibitory activity with IC50 of 4.62, 1.18, 1.38, 1.97, 8.83 and 4.18 mu M, respectively. Four other compounds (6b, 6d, 7b and 8a) showed moderate pim-1 inhibition. The most active compounds were tested for their cytotoxic activity on three cell lines [MCF7, HCT116 and PC3]. Compounds 7a [the 2-(2-chlorophenyl)-2,3-dihydro derivative] and 7d [the 2-(2-(trifluoromethyl)-phenyl)-2,3-dihydro derivative] displayed the most potent cytotoxic effect on the three cell lines tested consistent with their highest estimated pim-1 IC50 values.
引用
收藏
页码:457 / 467
页数:11
相关论文
共 50 条
  • [31] Eco-friendly synthesis of novel cyanopyridine derivatives and their anticancer and PIM-1 kinase inhibitory activities
    Abouzid, Khaled A. M.
    Al-Ansary, Ghada H.
    El-Naggar, Abeer M.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 134 : 357 - 365
  • [32] Synthesis of tetrahydropyrazolo-quinazoline and tetrahydropyrazolo-pyrimidocarbazole derivatives as potential anti-prostate cancer agents and Pim-1 kinase inhibitors
    Mohareb, Rafat M.
    Abbas, Nermeen S.
    Mohamed, Abeer A.
    MEDICINAL CHEMISTRY RESEARCH, 2017, 26 (06) : 1073 - 1088
  • [33] Synthesis and applications of carbon materials converted from PIM-1
    Kim, Byoung Gak
    Bok, Changsuk
    Kim, Young Seok
    Won, Jong Chan
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [34] Integrated molecular docking, 3D QSAR and molecular dynamics simulation studies on indole derivatives for designing new Pim-1 inhibitors
    Peddi, Sudhir Reddy
    Peddi, Saikiran Reddy
    Sivan, Sreekanth
    Veerati, Radhika
    Manga, Vijjulatha
    JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, 2020, 40 (01) : 1 - 14
  • [35] Docking study yields four novel inhibitors of the protooncogene Pim-1 kinase
    Pierce, Albert C.
    Jacobs, Marc
    Stuver-Moody, Cameron
    JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (06) : 1972 - 1975
  • [36] Uses of dimedone for the synthesis of thiazole derivatives as new anti-tumor, c-Met, tyrosine kinase, and Pim-1 inhibitions
    Rafat M. Mohareb
    Thomas M. Klapötke
    Elena Reinhardt
    Medicinal Chemistry Research, 2018, 27 : 2494 - 2511
  • [37] Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach
    Mingfeng Shao
    Yiming Yuan
    Kun Yu
    Kai Lei
    Guonian Zhu
    Lijuan Chen
    Mingli Xiang
    Molecular Diversity, 2014, 18 : 335 - 344
  • [38] Uses of dimedone for the synthesis of new heterocyclic derivatives with anti-tumor, c-Met, tyrosine, and Pim-1 kinases inhibitions
    Rafat M. Mohareb
    Fatma O. Al Farouk
    Wagnat W. Wardakhan
    Medicinal Chemistry Research, 2018, 27 : 1984 - 2003
  • [39] Uses of dimedone for the synthesis of thiazole derivatives as new anti-tumor, c-Met, tyrosine kinase, and Pim-1 inhibitions
    Mohareb, Rafat M.
    Klapoetke, Thomas M.
    Reinhardt, Elena
    MEDICINAL CHEMISTRY RESEARCH, 2018, 27 (11-12) : 2494 - 2511
  • [40] More than just a GPCR ligand: structure-based discovery of thioridazine derivatives as Pim-1 kinase inhibitors
    Li, Wei
    Wan, Xiaobo
    Zeng, Fanqi
    Xie, Yuting
    Wang, Yanli
    Zhang, Wei
    Li, Li
    Huang, Niu
    MEDCHEMCOMM, 2014, 5 (04) : 507 - 511